Aurobindo Pharma Acquires 26% Stake in Solar Firm, Executes Captive Power Agreement
New Delhi: Aurobindo Pharma Limited has completed the execution of a solar power purchase agreement with Swarnaakshu Solar Power Private Limited and acquired a 26% equity stake in the company as part of its captive solar power initiative under the Government of Telangana's captive power policy.
The latest development is in continuation of the company's earlier disclosures dated February 6, 2025, March 28, 2025, June 30, 2025, September 26, 2025, December 30, 2025 and March 30, 2026, through which it had informed the stock exchanges about the proposed execution of a power purchase agreement with Swarnaakshu Solar Power Private Limited for the procurement of solar power under Telangana's captive power policy and its proposed investment of up to Rs. 10.40 crore for acquiring 26% of the paid-up equity share capital and other securities of the company.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.